Loading company…
Suzhou pharmaceutical company, founded in 2019, developing bacteria-combination living drugs for immune-related diseases.
Suzhou Baimi Pharmaceutical Technology was established in 2019 and is based in Suzhou, China. The company develops microbial in vivo drugs, including multi-component bacterial combination drugs for immunomodulation-related diseases. It also works on precision intervention in patients' intestinal flora and precision nutritional provisioning. The company is at the Seed stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in